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Abstract
Spineless marine cuttlefish Sepiella inermis has been considered as a popular dietary 
cephalopod	species	in	Asian	and	Mediterranean	coasts.	Bioassay-directed	purifica-
tion of organic extract of S. inermis ensued in the characterization of two chromenyl 
derivatives. The studied compounds exhibited significantly greater antioxidant po-
tencies (IC50	≤	0.5	mg/ml)	when	compared	with	α-tocopherol.	The	substituted	1H-
isochromenyloxy-11-hydroxyethyl	 pentanoate	 isoform	 (compound	 1)	 efficiently	
inhibited the carbolytic enzymes along with key regulator of insulin secretion dipep-
tidyl	 peptidase-IV	 (IC50	 0.16	mg/ml).	 The	molecular	 docking	 simulations	 displayed	
optimum binding affinity of the compound 1 (−10.01	kcal/mol)	with	dipeptidyl	pepti-
dase-IV	and	lesser	inhibition	constant	(Ki	46.41	nM),	which	along	with	its	permissible	
hydrophobic-hydrophilic	balance	(log	Pow	~	2)	appeared	to	play	significant	roles	in	its	
greater antihyperglycemic activity compared to other studied chromenyl isoform. 
The greater antioxidant and antidiabetic properties of compound 1 could be utilized 
as	an	important	natural	lead	against	hyperglycemic-related	disorders.
Practical applications
The edible spineless marine cuttlefish Sepiella inermis are ubiquitously available in 
Asian	and	Mediterranean	coasts.	The	sequential	chromatographic	purification	of	the	
organic extract of S. inermis led to the identification of two pure chromenyl chemo-
types. The metabolites with substituted 1H-isochromenyloxy-11-hydroxyethyl	pen-
tanoate isoform (compound 1)	displayed	potential	antioxidative	and	antihyperglycemic	
activities compared to the chemotype (2)	bearing	3H-isochromen-5-yl	moiety.	The	
attenuating potential of chromenyl chemotype 1 against carbohydrate hydrolyzing 
enzymes and insulin secretion regulator attributed towards its efficiency as an im-
portant natural lead against postprandial hyperglycemia and incretin hormone regu-
lation to maintain glucose homeostasis in the biological system. The chromenyl 
metabolites isolated from S. inermis could be utilized as a functional food ingredient 
in	the	nutraceutical	formulations	against	hyperglycemic-related	disorders.
K E Y W O R D S
antihyperglycemic,	chromenyl	derivatives,	dipeptidyl	peptidase-IV,	molecular	docking	
simulations, Sepiella inermis
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1  | INTRODUC TION
Diabetes	 mellitus	 (type	 2	 diabetes)	 is	 one	 of	 the	 most	 arduous	
chronic metabolic syndromes of manifold etiologies distinguished 
by a failure of glucose homeostasis through disturbances in carbo-
hydrate, protein, and lipid metabolism as a result of impairment in 
insulin	secretion	and/or	insulin	action.	According	to	an	assessment	
of	International	Diabetes	Federation,	nearly	366	million	people	have	
been	affected	with	diabetes,	and	it	might	double	by	2,030,	whereas	
in India the diabetic population was found to be 40.9 million, which 
is	predicted	to	reach	up	to	60.9	million	by	2,025	(Mitra,	Dewanjee,	&	
Dey,	2012).	The	disturbance	in	the	glucose	homeostasis	arises	due	
to the imbalance between free radicals and antioxidants in cellular 
system, subsequently resulting in the development of pathogene-
sis	 of	 type	2	 diabetes	 (T2D)	 (Ullah,	Khan,	&	Khan,	 2016).		One	of	
the prominent therapeutic approaches to combat T2D is the use of 
carbohydrate digesting enzyme (α-glucosidase	 and	 α-amylase)	 in-
hibitors to prolong carbohydrate breakdown time, and thereby re-
ducing postprandial hyperglycemia by retarding glucose absorption 
rate	 (Elya	et	al.,	2015).	Acarbose	 is	one	of	 the	prominent	 inhibitor	
of carbohydrate metabolic enzymes in gastrointestinal tract, but it 
is accompanied by several side effects, such as diarrhea and other 
intestinal disturbances. Recently, the treatment of T2D is focused 
on the regulation of incretins or intestinal hormones namely glu-
cose-dependent	 insulinotropic	polypeptide	 (GIP)	and	glucagon-like	
peptide-1	(GLP-1).	GLP-1	plays	a	pivotal	role	in	regulation	of	blood	
glucose level by stimulating production of insulin, deterring glucagon 
secretion, delaying gastric emptying, regulating satiety and stimu-
lating differentiation and regeneration of islet β-cells	 (Wang	et	al.,	
2011).	About	50%–60%	of	total	insulin	is	formed	during	a	meal	re-
sults	from	GIP	and	GLP-1.	However,	GLP-1	has	very	short	half-lives,	
approximately	for	1–2	min	owing	to	proteolytic	cleavage	of	the	N-
terminal	dipeptide	specifically	for	L-alanine	or	L-proline	at	the	pen-
ultimate	position	by	dipeptidyl	peptidase-IV	 (DPP-IV)	 into	 inactive	
forms.	Inhibition	of	enzyme	DPP-IV	maintains	the	level	of	endoge-
nous	active	GLP-1	and	prolongs	 its	half-life	 (Purnomo,	Soeatmadji,	
Sumitro,	&	Widodo,	2015).	DPP-IV	is	a	serine	protease	localized	on	
cellular	surfaces.	DPP-IV	inhibitors	are	considered	to	be	a	safe	and	
unique approach for T2D management, as it retards blood glucose 
level through regulating hyperglycemia comprising optimum body 
weight management, improves glycated hemoglobin parameters, and 
inhibit	hypoglycemia	(Singh,	Jatwa,	Purohit,	&	Ram,	2017).	Synthetic	
peptide-derived	 DPP-IV	 inhibitors,	 namely	 saxagliptin,	 sitagliptin,	
and vildagliptin were approved for T2D management in the western 
countries,	although	the	durability	and	long-term	safety	remained	to	
be	proved.	Therefore,	a	systematic	research	for	food	based	DPP-IV	
inhibitors from the unexplored marine ecosystem appeared to be of 
great utility for developing nutraceutical supplements for ameliorat-
ing hyperglycemia and other related ailments.
Chromene or chromenone analogues were considered to be sig-
nificant chemistries of O-heterocyclic	compounds	with	greater	phar-
macological effects, including antioxidative and antiinflammatory 
pluralities	 (Appleton,	Sewell,	Berridge,	&	Copp,	2002).	The	antiox-
idant	and	antiinflammatory	 isochromenone	and	 furanyl-chromenyl	
metabolites were identified from estuarine mollusc, Paphia mala-
barica	 (Joy	&	Chakraborty,	2017)	and	bioactive	hexahydro-1H-iso-
chromenyl analogues were reported from Villorita cyprinoides	(Joy	&	
Chakraborty,	2018).	Anticancerous	hydrogenated	chromenone	was	
reported	 from	marine-derived	mycelium	of	Codium fragile	 (El-Beih,	
Kato,	Ohta,	&	Tsukamoto,	2007)	and	6-hydroxy-5-methylramulosin	
from Camptotheca acuminate	(Lin	et	al.,	2011).	The	naturally	derived	
chromenyl compounds with different pharmacologically active sub-
stituents have been vital for the development of nutraceutical and 
functional supplements.
Landing	and	consumption	of	cephalopods	have	increased	in	the	
last few decades due to their prominent nutritive values and vari-
ous	biological	activities	(Chakraborty	&	Joy,	2016;	Ramasamy	et	al.,	
2012).	The	cuttlefishes	belonging	to	Sepiidae	inhabit	in	the	tropical	
or temperate oceanic waters, and are important seafood items at 
Mediterranean,	East	Asian,	and	English	Channel	coasts.	Among	the	
cuttlefishes, Sepiella inermis	(spineless	cuttlefish)	forms	a	commer-
cially	important	fishery	in	Thailand,	India,	and	Sri	Lanka,	and	is	also	
targeted	by	small-scale	fisheries,	for	example	in	Indo-Chinese	wa-
ters	(Reid,	Jereb,	&	Roper,	2005).	From	the	nutritional	point	of	view,	
S. inermis	 has	 been	considered	 to	 be	 a	 rich	 source	 of	 long-chain	
polyunsaturated	 fatty	acids,	proteins,	well-balanced	vitamins	and	
essential	minerals	 (Chakraborty,	Joy,	&	Vijayagopal,	2016).	Earlier	
report of literature from our laboratory reported the free radical 
scavenging and antidiabetic activities of crude extract from the ed-
ible	tissues	of	this	particular	species	(Chakraborty	&	Joy,	2016).	As	
a continuing program to investigate bioactive chromenyl analogues 
from the economically important seafood species, the ethyl ace-
tate-methanol	(EA-MeOH)	extract	of	S. inermis was partitioned by 
sequential chromatographic fractionation to obtain two chromenyl 
derivatives.	Their	 structures	were	elucidated	using	Fourier	 trans-
form	infrared	(FTIR),	nuclear	magnetic	resonance	(NMR),	and	mass	
spectroscopic analyzes. The chromenyl analogues identified in the 
present	study	were	assessed	 for	antioxidant	activities	by	2,	2-di-
phenyl-1-picrylhydrazyl	 (DPPH)	 and	 2,	 2′-azino-bis	 (3-ethylbenz-
thiazoline-6-sulfonic	 acid)	 (ABTS+)	 scavenging	 assessments.	 The	
inhibitory properties of the studied compounds against the carbo-
lytic enzymes α-glucosidase	and	α-amylase	along	with	key	regulator	
of	 insulin	 secretion	dipeptidyl	 peptidase-IV	 (DPP-IV)	were	exam-
ined to recognize the utilization potential of these natural leads 
against	 hyperglycemic-related	 disorders.	 Structure-bioactivity	
inter-relationships	of	the	chromenyl	derivatives	were	examined	by	
different	physico-chemical	characteristics	of	the	studied	chrome-
nyl	isoforms.	The	modes	of	inhibition	of	DPP-IV	by	the	compounds	
were determined by in silico molecular docking simulations.
2  | MATERIAL S AND METHODS
2.1 | Sample collection and preparation of crude 
organic extracts
The specimens of S. inermis	(5.5	kg)	were	collected	freshly	from	the	
landing	 center	 of	Arabian	 Sea	 located	 at	 Lat	 8°48′	N,	 Long	78°9′	
E;	 Lat	 9°14′	 N,	 Long	 79º14′	 E,	 along	 the	 Southwestern	 coast	 of	
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Indian subcontinent. The species was washed to eliminate the dirt 
and	mucus	 remains.	 The	 visceral	 organs,	 including	 ink-gland	were	
judiciously separated from the edible part of the species. The ed-
ible portion were homogenated and freeze dried using a lyophilizer 
(Labogene	 Scanvac	Cool	 Safe,	Denmark)	 yielding	 the	 freeze-dried	
powder	(1890	g,	yield	34.36%).	The	lyophilized	powder	was	then	ex-
tracted	in	the	solvent	EA-MeOH	(1:1,	v/v,	1,500	ml	×	2)	using	soni-
cation	(7	hr)	in	the	presence	of	nitrogenous	atmosphere.	The	crude	
organic fraction was separated from species residue through filtra-
tion	by	Whatman-1	filter	paper	in	the	presence	of	anhydrous	sodium	
sulfate (Na2SO4),	and	the	filtrate	was	concentrated	by	utilizing	a	ro-
tary	evaporator	(55°C;	Heidolf,	Germany)	to	yield	the	crude	organic	
extract of S. inermis	(64	g,	yield	3.38%	on	dry	weight	basis).
2.2 | Chromatographic partitioning
The	 crude	 organic	 (EA-MeOH)	 extract	 of	S. inermis	 (64	g)	was	 re-
petitively partitioned utilizing column chromatography. The crude 
extract	was	mixed	with	60–120	mesh	 sized	 coarse	 silica	 (6	g)	 and	
packed	into	an	open	glass	column	(110	cm	×	5	cm)	charged	with	silica	
gel	(60–120	mesh,	80	g).	The	column	was	initially	eluted	with	n-hex-
ane	 and	 the	 solvent	 system	 increased	 by	 EA	 and	MeOH,	 to	 yield	
six column fractions (SI1 through SI6).	 The	 bioactive	 properties	 of	
the column fractions SI1-6 were assessed, and SI5 was preferred for 
further purification due to their higher antidiabetic activity against 
DPP-IV	(IC50	0.74	mg/ml)	and	free	radical	potencies	(IC50	<	0.85	mg/
ml)	(Table	S1).	The	fraction	SI5	(12.75	g;	19.92%)	was	further	purified	
by	vacuum-liquid	chromatographic	experimentation	on	the	column	
(46	cm	×	4	cm)	 with	 230–400	 meshed	 fine	 silica	 using	 increasing	
polar gradient of n-hexane/chloroform	(CHCl3)/MeOH	to	obtain	18	
fractions	(30	ml	each),	which	were	pooled	to	eight	subgroups	(SI5-1–
SI5-8)	 after	 thin	 layer	 chromatographic	 (TLC)	 (CHCl3:MeOH,	 8:2	
v/v)	analyses.	The	subfraction	SI5–7	 (40%	MeOH:CHCl3;	2,310	mg;	
18.04%)	 displayed	 greater	 bioactive	 potencies	 against	 DPPH	 and	
DPP-IV	(IC50	<	0.6	mg/ml)	when	compared	with	other	subfractions,	
and hence was considered for purification of bioactives. The frac-
tion SI5-7	was	purified	using	preparative	reversed-phase	high-pres-
sure	 liquid	 chromatography	 (RP-HPLC,	 C18-1.4	cm	×	25	cm,	 5	µm)	
with	 acetonitrile	 (MeCN)/MeOH	 (90:10	 v/v;	 10	ml/min)	 to	 yield	
compounds 1 (Rt	11.2	min,	92	mg)	and	2 (Rt	17.1	min,	126	mg),	which	
were	 found	 to	be	homogeneous	 in	TLC	 (CHCl3/MeOH,	80:20	v/v)	
and	RP-HPLC	(MeOH:MeCN,	10:90	v/v).
2.3 | Spectroscopic characterization of the 
purified compounds
NMR spectroscopic experiments, such as proton NMR (1H	NMR),	car-
bon NMR (13C	NMR),	along	with	two-dimensional	proton	correlation	
spectroscopy (1H-1H	COSY)	and	heteronuclear	multiple-bond	corre-
lation	spectroscopy	(HMBC)	were	conducted	with	a	Bruker	Avance	
DPX	 500	 NMR	 spectrometer	 using	 an	 internal	 standard	 (tetra-
methylsilane)	(Bruker,	Karlsruhe,	Germany),	whereas	the	compounds	
were dissolved in deuterated chloroform (CDCl3).	 NMR	 spectral	
analyses	were	carried	with	MestReNova	version	7.1.1-9649©	2012	
(Mestrelab	Research,	S.L.,	Spain).	FTIR	spectral	data	were	recorded	
on	 FTIR	 spectrophotometer	 (Perkin-Elmer	 2000,	 USA)	 between	
4,000 and 400 cm−1	scan	 range	 (Perkin-Elmer,	MA,	USA).	Ultra-vi-
olet	 (UV)	spectral	data	were	 recorded	with	a	ultra-violet	 (UV–VIS)	
spectrophotometer	(AquaMate-8000,	Thermo	Scientific,	USA).	Gas-
chromatographic	 mass-spectroscopic	 (GC-MS)	 experiments	 were	
conducted	on	a	Perkin-Elmer	instrument	(Clarus-680,	MA,	USA)	by	
electronic-impact	ionization	mode,	and	the	components	resolved	by	
a	capillary	column	(Elite-5;	50	m	×	220	µm	i.d.,	0.25	μm	film).
2.3.1 | 11‐(3,4,4a,5,8,8a‐Hexahydro‐8‐methoxy‐4‐
methyl‐1H‐isochromen‐4‐yloxy)‐11‐hydroxyethyl 
pentanoate (1)
Brown	oily;	UV	λmax	MeOH (log ε	2.42):	254	nm;	[α]
26
D	−19.9°	(CHCl3, 
c0.014);	 TLC	 (silica	 GF-254;	 CHCl3/MeOH,	 80:20	 v/v)	 Rf:	 0.37;	
Rt (RP-C18	 HPLC,	 Shimadzu,	 Japan;	 C18	 25	cm	×	0.46	cm,	 5	µm;	
MeOH:MeCN,	 10:90	 v/v):	 2.737	min	 (Fig.	 S1);	 IR	 (cm−1)	 (stretch-
ing ν, bending δ, rocking ρ):	3,445	 (br,	O–Hν),	2,924,	2,855	 (C–Hν),	
1730	 (C=Oν),	 1,476,	 1,386	 (C–Hδ),	 1,233	 (C–Hρ),	 1,088	 (C–O–Cν),	
971	(=C–Hδ).	1H	NMR	(500	MHz,	CDCl3):	δ	5.37	(1H,	t,	5.3Hz),	5.35	
(1H,	q,	4.0Hz),	5.21	 (1Hα,	 t),	4.39	 (1Hα,	d),	4.14	 (1Hβ,	d),	3.93	 (2H,	
d),	3.73	 (2H,	 s),	3.38	 (1Hα,	 t),	 3.29	 (3H,	 s),	2.30	 (2H,	 t),	2.19	 (1Hβ, 
t),	2.09	(1Hβ,	t),	2.03	(2H,	t),	1.58	(2H,	m),	1.29	(2H,	s),	1.27	(3H,	s),	
0.89	(3H,	t);	13C	NMR	(125	MHz,	CDCl3):	δ	173.64,	129.99,	129.69,	
70.42,	70.36,	69.12,	66.24,	63.55,	62.97,	54.34,	34.15,	31.94,	29.78,	
29.39,	27.24,	24.92,	22.70	14.12;	1H-1H	COSY	and	HMBC	data	were	
given in Table 1. EIMS: found m/z	342.2048	[M]+, cal. for C18H30O6 
342.2042	(∆	=	1.7	ppm).
2.3.2 | Methyl 9‐(4,4a,5,8‐tetrahydro‐3‐oxo‐3H‐
isochromen‐5‐yl)hexanoate (2)
Dark	 yellow	oily;	UV	λmax	MeOH (log ε	 2.24):	 198	nm;	 [α]
26
D	 −21.3°	
(CHCl3,	 c0.015);	 TLC	 (silica	 GF-254;	 CHCl3/MeOH,	 80:20	 v/v)	 Rf: 
0.49; Rt	 (RP-C18	HPLC;	MeOH:MeCN,	10:90	v/v):	4.38	min	 (Figure	
S2);	 IR	 (cm−1):	 2,925,	 2,856	 (C–Hν),	 1732	 (C=Oν),	 1,396	 (C–Hδ),	
1,228	 (C–Hρ),	 1,085,	 1,053	 (C–O–Cν),	 969,	 924	 (=C–Hδ).	 1H	NMR	
(500	MHz,	 CDCl3):	 δ	 6.20	 (1H,	 s),	 5.37	 (1H,	 dt,	 5.3,	 2.0	Hz),	 5.35	
(1H,	 t,	2.2Hz),	3.65	 (3H,	 s),	2.83	 (2H,	d),	2.81(1Hβ,	 t),	2.37	 (2H,	d),	
2.29	(2H,	t),	2.06	(1Hβ,	t),	1.97	(1Hα,	m),	1.60	(2H,	q),	1.27	(2H,	m),	
0.86	(3H,	t);	13C	NMR	(125	MHz,	CDCl3):	δ	174.43,	173.60,	132.03,	
129.32,	 128.56,	 127.86,	 51.44,	 39.78,	 34.11,	 31.91,	 29.67,	 25.62,	
24.95,	22.68,	20.54,	14.1;	1H-1H	COSY	and	HMBC	data	were	given	in	
Table 1. EIMS: found m/z	278.1522	[M]+, cal. for C16H22O4	278.1518	
(∆	=	1.4	ppm).
2.4 | Antioxidant and antidiabetic activities
The antioxidant properties of the studied chromenyl analogues 
(1–2)	 isolated	 from	S. inermis were	 resolved	by	 in	 vitro	DPPH	and	
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ABTS+	 (Odeleye	 et	 al.,	 2016;	 Wojdylo,	 Oszmianski,	 &	 Czemerys,	
2007)	radical-scavenging	analyses.	Antidiabetic	potential	of	 the	ti-
tled	 compounds	 were	 assessed	 using	 the	 dipeptidyl	 peptidase-IV	
enzyme	 (DPP-IV,	human	recombinant)	 inhibitory	potential	 (Kojima,	
Ham,	&	Kato,	1980)	as	well	as	the	 inhibition	capability	toward	the	
carbolytic enzymes α-amylase	 (procured	 from	 porcine	 pancreas)	
and α-glucosidase	(from	yeast),	according	to	the	method	described	
earlier	(Hamdan	&	Afifi,	2004).	The	results	were	expressed	as	50%	
inhibitory concentration (IC50,	 in	mg/ml),	which	was	obtained	from	
the graph plotted with concentrations of sample against percentage 
inhibition toward enzyme/radical.
2.5 | Structure‐bioactivity interrelationship analysis
The molecular physicochemical characteristics, such as hydro-
phobic (logarithmic value of octanol/water partition coefficient, 
log Pow),	 polar	 (polarizability	 Pl	 and	 topological	 polar	 surface	 area	
tPSA),	and	bulk	 (Pr	parachor,	MR	molar	refractivity,	and	MV	molar	
volume)	(Joy	&	Chakraborty,	2018)	parameters	were	used	to	study	
the	structure-bioactivity	interrelationship	analysis	of	the	chromenyl	
derivatives.	 These	 parameters	 were	 deduced	 by	 ACD	 (Advanced	
Chemistry	 Development)	 ChemSketch	 (version	 12.0;	 Canada)	 and	
ChemDraw	Ultra	 (version	12.0;	Cambridge	 Soft	Corporation,	MA,	
USA)	programs.
2.6 | In silico molecular docking analysis
In silico molecular docking analyses of the purified chromenyl 
analogues were demonstrated by utilizing the docking software 
(Autodock	4.0,	version	1.5.6),	to	establish	the	stable	ligand-protein	
conformation. The studied compounds were drawn with Chemsketch 
software	 (version	3.5)	and	saved	as	MDL-molfiles,	and	finally	con-
verted	to	PDB	format	with	Open	Babel	GUI	(version	2.4.1).	The	crys-
tal	structure	of	DPP-IV	(PDB:	3F8S;	resolution	2.0	Å)	 (Ammirati	et	
TA B L E  1   NMR spectroscopic data (in CDCl3)
a,b of chromenyl compounds, 1-2 isolated from S. inermis
C. No. 13C
1H(int.,mult.,J in 
Hz)b 
1H‐1H 
COSY HMBC C. No. 13C 1H(int.,mult.,J in Hz)b 
1H‐1H 
COSY HMBC
1 63.55 3.93(2H,d) H-8a C-3,4,8a 1 128.56 6.20(1H,s) – C-3,8a
2 – – – – 2 - – – –
3 66.24 3.73(2H,s) – C-4 3 173.60 – – –
4 69.12 – – – 4 31.91 2.37(2H,d) H-4a C-3
4a 31.94 2.09(1Hβ,t) H-8a C-3,4 4a 39.78 2.81(1Hβ,t) H-5 C-3,6,8a
5 27.24 2.03(2H,t) H-6 C-6,7,8a 5 20.54 2.06(1Hβ,t) H-6,	H-9 C-6,7,9
6 129.69 5.35(1H,q,4.0Hz) - C-5,4a 6 132.03 5.35(1H,t,2.2Hz) – C-5,7,8,9
7 129.99 5.37(1H,t,5.3Hz) H-8 - 7 127.86 5.37(1H,dt,5.3,2.0Hz) H-8 C-6,8a
8 70.36 3.38(1Hα,t) H-8a C-9 8 25.62 2.83(2H,d) – C-6,7,8a
8a 29.39 2.19(1Hβ,t) – C-4a,5,7 8a 129.32 – – –
9 54.34 3.29(3H,s) – C-8 9 29.67 1.97(1Hα,m) H-10,	H-14 C-5,6,12
10 29.78 1.27(3H,s) – C-4,4a 10 24.95 1.60(2H,q) H-11 C-9,11,12
11 70.42 5.21(1Hα,t) H-12 C-4,12 11 34.11 2.29(2H,t) – C-12
12 62.97 4.14(1Hβ,d) – C-11,13 12 174.43 – – –
  4.39(1Hα,d) – – 13 51.44 3.65(3H,s) – C-12
13 173.64 – – – 14 22.68 1.27(2H,m) H-15 C-9,15
14 34.15 2.30(2H,t) H-15 C-13,15 15 14.10 0.86(3H,t) – C-9,14
15 24.92 1.58(2H,m) H-16 C-13,14,16 – – – – –
16 22.70 1.29(2H,m) H-17 C-15,17 – – – – –
17 14.12 0.89(3H,t) – C-16,14 – – – – –
Note.	Assignments	were	made	with	the	aid	of	1H-1H	COSY,	HSQC,	HMBC,	and	NOESY	experiments.
aNMR	spectra	recorded	using	Bruker	AVANCE	III	500	MHz	(AV	500)	spectrometers.	bValues	in	ppm,	multiplicity,	and	coupling	constants	(J	=	Hz)	are	
indicated in parentheses. 
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al.,	2009)	was	obtained	from	RCSB-protein	databank,	wherein	 the	
water	 molecules	 were	 excluded	 from	 target	 proteins,	 and	 Swiss-
PdbViewer	(SPDBV	v4.1.0)	was	utilized	for	the	energy	minimization	
of enzyme. Molecular docking studies of the ligands were performed 
to	evaluate	the	optimum	binding	modes	between	the	DPP-IV	active	
sites and the studied metabolites. The docking studies were per-
formed	using	AutoDock	4	(AutoDock	Tools	version	1.5.6)	and	bound	
ligands, cofactors and water were removed. The target enzyme was 
accounted for partial atomic Kollman charges designation, and polar 
hydrogens. Torsion bonds of the studied chromenyl analogues were 
chosen	and	defined,	wherein	the	3D-grid	box	was	created	by	Auto-
Grid	calculation	to	calculate	the	coupling	energies	on	the	DPP-IV	co-
ordinates.	Grid	map	set	values	for	docking	of	DPP-IV	were	selected	
as x	=	8.512,	 y	=	5.755,	 z	=	52.694	 (58	Å	×	66	Å	×	66	Å)	 points.	
Running of the docking calculation was demonstrated by utilizing 
Cygwin-1/Cygwin-2,	and	root-mean-square	deviation	to	assess	low-
est	binding	energy.	USCF	chimera	1.11.2	 (University	of	California,	
San	Francisco-UCSF)	programming	was	employed	for	visual	repre-
sentation	of	results	 to	recognize	H-bonding	relations	between	the	
designated	chromenyl	derivatives	and	target	DPP-IV.
2.7 | Statistical analysis
The statistical software SPSS (Statistical Program for Social Sciences, 
version	 13.0;	USA)	was	 utilized	 to	 ascertain	 the	 significant	 differ-
ence	using	ANOVA	(one-way	analysis	of	variance)	between	means.	
The results were presented as the mean of replicate experiments 
with	5%	level	of	significance	(p	≤	0.05).
3  | RESULTS AND DISCUSSION
3.1 | General
The marine cephalopods belonging to the family Sepiidae repre-
sent a prominent share in the fishery sector, and were designated 
to possess different bioactive metabolites with respect to various 
pharmacological	 activities	 (Chakraborty	&	 Joy,	2016).	 The	present	
study deals with isolation of bioactive chromenyl analogues from the 
EA-MeOH	extract	of	spineless	cuttlefish	S. inermis using extensive 
spectroscopic techniques. The bioactive properties of the isolated 
chromenyl analogues with respect to their antioxidant and antidia-
betic activities using in vitro pharmacological models were assessed.
3.2 | Chromatographic fractionation and structural 
characterization of chromenyl derivatives from 
S. inermis
The	crude	EA-MeOH	extract	of	S. inermis was firstly fractionated to 
five	key	sub-fractions	(SI1–SI6),	and	among	which	SI5 displayed signif-
icantly	greater	recovery	(20%)	than	SI1 through SI3 and SI6	(<	20%).	
The	 sub-fractions,	 SI5 also exhibited higher antioxidant (IC50	 DPPH	
scavenging 0.84 mg/ml; IC50	ABTS+	scavenging	0.82	mg/ml)	and	antidiabetic	
(IC50	DPP-IV	 inhibitory	 0.74	mg/ml)	 properties	 than	 those	 displayed	 by	
others (IC50	>	0.80	mg/ml)	(Table	S1).	Therefore,	SI5 was selected for 
downstream chromatographic purification to obtain two chromenyl 
derivatives (1–2).	The	structures	of	the	studied	compounds	were	in-
terpreted	by	inclusive	spectroscopic	techniques	(Figure	1).
3.2.1 | 11‐(3,4,4a,5,8,8a‐Hexahydro‐8‐methoxy‐4‐
methyl‐1H‐isochromen‐4‐yloxy)‐11‐hydroxyethyl 
pentanoate (1)
The	 hexahydro	 isochromenyl	 analogue,	 11-(hexahydro-8-meth-
oxy-4-methyl-1H-isochromen-4-yloxy)-11-hydroxyethyl	pentanoate	
(1)	 was	 sequentially	 fractionated	 as	 brown	 oily	 through	 repeated	
chromatographic purifications. The mass spectrum envisaged the 
occurrence of its molecular ion peak at m/z	342,	which	supported	the	
molecular formula of the titled compound as C18H30O6 through the 
broad	IR/NMR	analyses	(Table	1,	Figures	S3–S11).	The	four	degrees	
of unsaturations were deduced to correspond toward two double 
bonds and two ring systems. The absence of aromatic protons (δ 
6.5–8.5)	signified	the	absence	of	aromatic	rings	in	the	structure.	The	
distortionless enhancement by polarization transfer (DEPT135)	 and	
13C shift resonances displayed 18 carbons, which include one ester 
carbonyl (δ	173.64),	alkenic	carbons	(δ	129–130),	one	hydroxylated	
carbon (δ	 70.36),	 four	 oxygenated	 carbons	 {δ	 63.55,	 66.24,	 69.12	
(quaternary	 carbon),	 54.34	 (–OCH3)	 and	 62.97	 [–C(=O)–O–CH3]} 
along with shielded methyls, methylenes, and methines in the range 
of δ	34–14.	The	one-dimensional	NMR	resonances	along	with	het-
eronuclear	single	quantum	coherence	spectroscopy	(HSQC)	(Figure	
S7)	suggested	the	possibilities	of	one	methylene	of	oxygenated	end	
F I G U R E  1   (a)	Photographic	representation	of	S. inermis 
(spineless	cuttlefish).	Structural	representations	of	the	chromenyl	
analogues,	(b)	11-(hexahydro-8-methoxy-4-methyl-1H-
isochromen-4-yloxy)-11-hydroxyethyl	pentanoate	(compound	1)	
and	(c)	methyl	9-(tetrahydro-3-oxo-3H-isochromen-5-yl)hexanoate	
(compound 2)	purified	from	S. inermis
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of ester group (δH	4.14,	4.39/δC	62.97),	one	methylene	of	carbonyl	
end of ester group (δH	2.30/δC	34.15),	one	disubstituted	sp2 alkene 
(δH	5.35/δC	129.69;	δH	5.37/δC	129.99);	 two	oxygenated	methyl-
enes (δH	3.93/δC	63.55;	δH	3.73	singlet/δC	66.24);	one	each	of	oxy-
genated methine (δH	3.38/δC	70.36),	oxygenated	methyl	(δH	3.29/
δC	54.34)	and	deshielded	hydroxylated	methine	(δH	5.21/δC	70.42).	
The presence of oxygenated singlet methylene at δH	3.73	and	oxy-
genated methylene at δH	3.93	with	doublet	splitting	suggested	that	
these groups might be shared by a common oxygen atom and the 
proton at δH	3.93	was	assigned	at	H-1	position.	The	 1H-1H	COSY	
correlations suggested two spin systems in the oxygenated bicy-
clic ring, which were found to be δH	3.93	 (attributed	 to	H-1)/2.19	
(H-8a)/3.38	 (H-8)/5.37	 (H-7)	 including	 δH	2.09	 (H-4a)/2.19	 (H-8a)	
and δ	2.03	(H-5)/5.35	(H-6)	that	supported	the	basic	skeleton	of	hex-
ahydro	isochromenyl	ring	(Figure	2A,	S6).	This	oxygen-enclosed	hex-
ahydro isochromenyl ring was further established with the help of 
long-range	HMBCs	from	δ	3.93	(H-1)	to	δ	29.39	(C-8a);	δ	2.03	(H-5)	
to δ	129.69	(C-6),	129.99	(C-7),	29.39	(C-8a);	δ	5.35	(H-6)	to	δ	27.24	
(C-5)	and	δ	2.19	 (H-8a)	 to	δ	31.94	 (C-4a),	129.99	 (C-7),	27.24	 (C-5)	
(Figure	2A,	S8).	Also,	the	position	of	oxygenated	singlet	methylene	at	
δH	3.73	(assigned	to	H-3)	and	its	attachment	to	the	oxygenated	qua-
ternary carbon at δ	69.12	(C-4)	in	the	hexahydro	isochromenyl	ring	
were	confirmed	by	the	HMBC	relations	from	δ	3.73	(H-3)	to	δ	69.12	
(C-4);	δ	2.09	(H-4a)	to	δ	66.24	(C-3),	69.12	(C-4)	and	δ	3.93	(H-1)	to	δ 
66.24	(C-3),	69.12	(C-4).	An	oxygenated	deshielded	singlet	signal	at	
δ	3.29	with	an	integral	of	three	suggested	the	presence	of	methoxy	
group, and its attachment to the basic hexahydro isochromenyl ring 
were	suggested	by	the	HMBCs	from	δ	3.29	(H-9)	to	δ	70.36	(C-8)	and	
δ	3.38	(H-8)	to	δ	54.34	(C-9).	The	hexahydro-1H-isochromene	part	
of	pericoannosin	A	was	similar	to	the	studied	compound	(Zhang	et	
al.,	2015).	The	reported	compound	enclosed	a	trisubstituted	alkene	
and	side	chains	at	C-1	and	C-3	positions,	whereas	the	studied	com-
pound	enclosed	a	disubstituted	alkene	and	side	chains	at	C-4	and	
C-8	positions.	An	upfield	singlet	signal	at	δH	1.27	(proton	integral	of	
three; δC	29.78,	HSQC)	was	exhibited	by	its	HMBC	correlations	with	
the carbon traces at δ	 69.12	 (C-4),	 31.94	 (C-4a),	which	 supported	
the direct attachment of methyl to the quaternary carbon enclosed 
in	 the	bicyclic	 ring.	The	COSY	 relations	between	 the	protons	 at	δ 
5.21	 (H-11)/4.14,	4.39	 (H-12)	 and	δ	2.30	 (attributed	 to	H-14)/1.58	
(H-15)/1.29	 (H-16)/0.89	 (H-17)	 established	 a	 side	 chain	with	 ester	
linkage.	The	HMBC	couplings	from	δ	5.21	(H-11)	to	δ	62.97	(C-12);	δ 
4.14	(H-12)	to	δ	70.42	(C-11),	173.64	(C-13);	δ	2.30	(H-14)	to	δ	173.64	
(C-13),	24.92	(C-15);	δ	1.58	(H-15)	to	δ	173.64	(C-13),	34.15	(C-14),	
22.70	(C-16);	δ	1.29	(H-16)	to	δ	24.92	(C-15),	14.12	(C-17)	and	δ 0.89 
(H-17)	 to	δ	 22.70	 (C-16),	34.15	 (C-14)	 appropriately	 supported	 the	
presence of hydroxyethyl pentanoate chain. The attachment of hy-
droxyethyl	pentanoate	chain	at	C-4	(δ	69.12)	was	confirmed	by	the	
HMBC	from	δ	5.21	(H-11)	to	δ	69.12	(C-4).	The	comparatively	lesser	
coupling	constants	of	4.0	and	5.3	Hz	were	found	to	correspond	to-
ward the protons at δ	5.35	(H-6)	and	δ	5.35	(H-7),	respectively.	The	
later established that the disubstituted alkene was oriented as cis 
(Z)	in	the	hexahydro	isochromenyl	ring	system.	The	stereochemical	
orientations	of	the	chiral	centers	at	C-4,	C-4a,	C-8,	and	C-8a	were	
ascribed through the detailed nuclear overhauser effect spectros-
copy	(NOESY)	experiments	(Figure	2B,	S9).	The	NOESY	resonances	
among δ	2.09	(H-4a),	4.14	(Hβ-12)	and	δ	2.19	(H-8a)	suggested	their	
equal plane of symmetry, and were arbitrarily aligned as β-protons.	
Thus, the cis orientation of ring junction of hexahydro isochromenyl 
framework was established, and the α-disposition	of	 the	hydroxy-
ethyl	pentanoate	chain	at	C-4	was	confirmed.	The	NOESY	couplings	
between the protons at δ	3.38	(H-8),	4.39	(Hα-12),	and	5.21	(H-11)	
suggested their equal plane of symmetry, and these did not display 
any	NOESY	correlations	with	 the	β-aligned	protons,	 therefore,	as-
signed as α-oriented	 protons.	 Thus,	 the	 β-orientation	 of	 hydroxyl	
group	 at	 C-11	 and	methoxyl	 group	 at	 C-8	were	 appropriately	 as-
signed	 (Figure	 S9).	 The	 basic	 hexahydro-isochromenyl	 skeleton	 of	
the studied compound isolated from S. inermis was similar to hexa-
hydro-isochromenyl-meroterpenoids	 that	 was	 previously	 reported	
from the mollusc, V. cyprinoides	 (Joy	&	Chakraborty,	2018).	The	 IR	
spectrum of compound 1 exhibited the stretching absorptions at 
2,924–2,855,	1,730	and	3,445	cm−1, that denoted the presence of 
alkanes,	ester	carbonyl,	and	hydroxyl	moieties,	respectively	(Figure	
S10).	The	molecular	ion	peak	at	m/z	342	([M]+)	was	found	to	undergo	
F I G U R E  2   (A)	1H-1H	COSY,	HMBC	and	(B)	NOESY	correlations	
of	11-(hexahydro-8-methoxy-4-methyl-1H-isochromen-4-
yloxy)-11-hydroxyethyl	pentanoate	(compound	1)	and	(C	and	
D)	methyl	9-(tetrahydro-3-oxo-3H-isochromen-5-yl)hexanoate	
(compound 2).	The	key	1H-1H	COSY	couplings	were	represented	
in	bold-face	bonds.	The	key	HMBC	couplings	have	been	
represented	by	the	double-barbed	arrow.	The	NOESY	relations	
were represented by double sided arrows, wherein the red and 
blue colored arrows indicated the beta (β-)	and	alpha	(α-)	protons,	
respectively
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McLafferty	rearrangement	with	the	elimination	of	propene	to	yield	
11-(hexahydro-8-methoxy-4-methyl-isochromen-4-yloxy)-11-hy-
droxyethoxy)ethanol	 fragment	 at	m/z	 300	 (1B)	 (Figures	 S11–S12).	
The fragment at m/z	300	(1B)	underwent	McLafferty	rearrangement	
to afford the base peak at m/z	60	(1D,	acetic	acid)	along	with	a	frag-
ment at m/z 240 (1C).	The	latter	underwent	McLafferty	rearrange-
ment, which could result in the formation of the base peak at m/z	60	
(1E,	acetic	acid)	along	with	an	ion	peak	at	m/z 180. The elimination 
of one methoxy radical from the fragment at m/z 180 yielded tet-
rahydro-4-methyl-1H-isochromene	fragment	with	m/z 149 (1G).	The	
repeated elimination of C3H4
••	and	3	methyl	radicals	from	the	ion	at	
m/z 149 yielded the fragments at m/z 112 (1H,	attributed	to	3,6-di-
hydro-3,4-dimethyl-2H-pyran)	and	m/z	70	(1J, attributed to vinyloxy 
ethene),	respectively.
3.2.2 | Methyl 9‐(4,4a,5,8‐tetrahydro‐3‐oxo‐3H‐
isochromen‐5‐yl)hexanoate (2)
The	previously	undisclosed	 tetrahydro	oxo-isochromenyl	deriva-
tive,	 named	 as	 methyl	 9-(4,4a,5,8-tetrahydro-3-oxo-3H-isoch-
romen-5-yl)hexanoate	 (2)	 was	 isolated	 through	 the	 repetitive	
chromatographic fractionations, as dark yellow colored oily com-
pound. The mass spectrum demonstrated a molecular ion peak at 
m/z	278,	and	exhaustive	IR/NMR	analyses	suggested	its	molecu-
lar formula as C16H22O4	 (Table	1,	Figures	S13–S21).	The	degrees	
of unsaturations were found to be five, which comprised of three 
double bonds including one carbonyl and two cyclic systems. 
The DEPT along with 13C NMR resonances suggested the occur-
rences	of	15	carbon	atoms	including	those	belonging	to	two	esters	
(δ	 173–174),	 alkenic	 (δ	 127–132),	 one	 oxygenated	 end	 of	methyl	
carbon	 of	 ester	 {δ	 51.44	 [−C(=O)–O–CH3]} along with shielded 
methyls, methylenes, and methines (at δ	14–40).	The	1H/13C NMR 
along	with	HSQC	confirmed	the	probabilities	of	one	each	of	me-
thyl group at oxygenated end of ester (δH	3.65/δC	51.44),	meth-
ylene at carbonyl end of ester (δH	2.29/δC	34.11),	disubstituted	
sp2 alkene (δH	5.35/δC	132.03;	δH	5.37/δC	127.86);	and	trisubsti-
tuted sp2 alkene (δC	129.32;	δH	6.20/δC	128.56)	(Figure	S17).	The	
greatly deshielded singlet proton trace at δ	6.20	exhibited	HSQC	
correlation with the carbon at δ	128.56	 (arbitrarily	positioned	at	
C-1)	suggesting	that	it	was	not	a	part	of	any	aromatic	group.	This	
signal might be related to an alkene, which was positioned be-
tween the highly electron withdrawing groups, such as ester. The 
HMBC	couplings	from	δ	6.20	 (H-1)	 to	δ	173.60	 (C-3)	and	129.32	
(C-8a)	 further	 supported	 that	 the	 proton	 at	 δ	 6.20	was	 directly	
bonded to the oxygenated end of carboxylate group, which was 
the part of an ester enclosed bicyclic ring system. The 1H-1H	COSY	
couplings displayed two spin systems in the carboxylated bicyclic 
ring, which were δH	 2.37	 (attributed	 to	 H-4)/2.81	 (H-4a)/2.06	
(H-5)/5.35	(H-6)	including	δH	5.37	(H-7)/2.83	(H-8)	that	supported	
the	 partial	 skeleton	 of	 tetrahydro	 oxo-isochromenyl	 ring	 frame-
work	(Figure	2C,	S16).	This	was	further	corroborated	through	the	
long	range	HMBC	couplings	from	δ	2.37	(H-4)	to	δ	173.60	(C-3);	δ 
2.81	(H-4a)	to	δ	173.60	(C-3),	132.03	(C-6),	129.32	(C-8a);	δ	2.06	
(H-5)	to	δ	132.03	(C-6),	127.86	(C-7);	δ	5.35	(H-6)	to	δ	20.54	(C-5),	
127.86	 (C-7),	 25.62	 (C-8);	δ	 5.37	 (H-7)	 to	δ	 132.03	 (C-6),	 129.32	
(C-8a)	 and	 δ	 2.83	 (H-8)	 to	 δ	 132.03	 (C-6),	 127.86	 (C-7),	 129.32	
(C-8a)	(Figure	2C,	S18).	The	carboxylate	enclosed	bicyclic	ring	skel-
eton	could	be	comparable	to	the	tetrahydro-isochromenone	ana-
logue	isolated	from	yellow-foot	mollusc	Paphia malabarica (Joy	&	
Chakraborty,	2017).	The	COSY	correlations	from	δ	1.97	(H-9)/1.60	
(H-10)/2.29	(H-11)	including	δ	1.97	(H-9)/1.27	(H-14)/0.86	(H-15)	
were	 supported	 by	 the	 HMBCs	 from	 δ	 1.97	 (H-9)	 to	 δ	 174.43	
(C-12);	δ	1.60	(H-10)	to	δ	174.43	(C-12),	29.67	(C-9);	δ	2.29	(H-11)	
to δ	174.43	(C-12);	δ	3.65	(H-13)	to	δ	174.43	(C-12);	δ	1.27	(H-14)	to	
δ	29.67	(C-9),	14.10	(C-15)	and	δ	0.86	(H-15)	to	δ	29.67	(C-9),	which	
established the partial structure of methyl hexanoate side chain. 
The	attachment	of	methyl	hexanoate	side	chain	to	tetrahydro	oxo-
isochromenyl	 ring	at	C-5	was	established	with	the	help	of	COSY	
interaction from δ	 2.06	 (H-5)/1.97	 (H-9)	 and	 long	 range	HMBCs	
from δ	2.06	 (H-5)	 to	δ	29.67	 (C-9);	δ	5.35	 (H-6)	 to	δ	29.67	 (C-9);	
δ	 1.97	 (H-9)	 to	δ	 20.54	 (C-5),	 132.03	 (C-6).	 The	 relatively	 lesser	
coupling	values	of	2.2	and	5.3	Hz	for	the	protons	at	δ	5.35	(H-6)	
and δ	5.35	 (H-7),	 respectively,	 suggested	 their	cis (Z)	orientation	
in	 the	 tetrahydro	 oxo-isochromenyl	 system.	 The	 stereochemical	
orientations	 of	 chiral	 centers	 at	 C-4a,	 C-5,	 and	C-9	were	 estab-
lished	 through	NOESY	 resonances	 (Figure	2D,	S19).	The	NOESY	
relation between δ	 2.81	 (H-4a)	 and	 δ	 2.06	 (H-5)	 suggested	 that	
these protons were aligned in an equal plane of symmetry, and 
therefore, arbitrarily positioned as β-protons.	However,	 the	pro-
ton at δ	1.97	(H-9)	did	not	display	any	NOESY	cross-peaks	with	the	
β-oriented	protons,	and	thus,	H-9	was	assigned	to	be	α-oriented.	
The IR spectrum of compound 2 displayed the stretching absorp-
tions	at	2,925–2,856	and	1732	cm−1 that signified the occurrences 
of	alkanes	and	ester	carbonyl	functionalities,	respectively	(Figure	
S20).	 The	molecular	 ion	 peak	 at	m/z	 278	 ([M]+)	 appeared	 to	 un-
dergo	characteristic	McLafferty	rearrangement	to	yield	the	base	
peak at m/z	74,	which	might	relate	to	methyl	acetate	fragment	(2C)	
along with a fragment at m/z	 206	 (2B)	 attributing	 to	 5-(but-10-
en-9-yl)-tetrahydro-1H-isochromen-3(4H)-one	 (Figures	 S21–S22).	
The fragment at m/z	206	 (2B)	underwent	McLafferty	 rearrange-
ment and bond cleavage to form a fragment at m/z	206	(2D).	The	
latter	on	McLafferty	rearrangement	afforded	a	peak	at	m/z	60	(2E, 
acetic	 acid)	 along	with	 a	 fragment	 at	m/z	 146	 {2F, attributed to 
2-(but-9-en-8-yl)-6-methylenecyclohexa-1,3-diene},	 which	 upon	
elimination of two methyl radicals yielded a fragment with m/z 
120 (2G).	 The	 repeated	 elimination	 of	 C3H7
•	 and	 CH2
•• radicals 
from the ion at m/z 1,120 yielded the fragments at m/z	 79	 (2H, 
attributed	 to	 cyclohexa-1,	3-diene)	 and	m/z	 67	 (2I, attributed to 
penta-1,	3-diene),	respectively.
3.3 | Bioactive properties of chromenyl derivatives 
from S. inermis
The antioxidant and antidiabetic properties of (1–2)	were	assessed	
by	DPPH/ABTS+ radical scavenging, and the target bioactivities were 
compared with the commercially available antioxidant α-tocopherol	
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(Table	2).	The	hexahydro	chromenyl	 analogue	 (1)	 exhibited	 signifi-
cantly	 higher	 ABTS+	 and	 DPPH	 scavenging	 properties	 (IC50	 0.33	
and	 0.38	mg/ml,	 respectively)	 than	 that	 possessed	 by	 its	 tetrahy-
dro	 oxo-isochromenyl	 chemotype	 (2)	 (IC50	 0.46	 and	 0.51	mg/ml,	
respectively)	 (p	<	0.05).	 The	 antioxidant	 activity	 of	 the	 chromenyl	
derivatives	were	previously	reported	from	the	bivalve	mollusc	(Joy	
&	Chakraborty,	2018),	which	corroborated	the	reported	free	radical	
scavenging activities of the chromenyl derivatives from the cephalo-
pod mollusc considered in the current study.
The in vitro antihyperglycemic effects of the purified chrome-
nyl chemotypes were determined through the inhibition of car-
bolytic enzymes α-glucosidase	 and	α-amylase,	which	 reduce	 the	
absorption of intestinal carbohydrates, and also inhibit the enzy-
matic	action	of	DPP-IV,	the	key	regulator	in	the	insulin	secretion.	
Among	the	compounds,	hexahydro	chromenyl	analogue,	1 exhib-
ited greater α-amylase	and	α-glucosidase	(IC50	0.27	and	0.19	mg/
ml,	respectively)	inhibiting	potential	compared	to	tetrahydro	oxo-
isochromenyl derivative 2 (IC50	0.36	and	0.28	mg/ml,	respectively).	
Likewise,	 the	 compound	1 showed	greater	DPP-IV	 inhibiting	 ac-
tivity (IC50	0.16	mg/ml)	compared	to	that	displayed	by	compound	
2 (IC50	 0.23	mg/ml).	 Inhibitors	 of	 the	 carbolytic	 enzymes	 could	
slow down the liberation of absorbable monosaccharides from the 
dietary complex carbohydrates, and could be considered as an ef-
fective strategy for the treatment of postprandial hyperglycemic 
spike by reducing gastrointestinal glucose absorption (Elya et al., 
2015).	 In	 the	 current	 study,	 the	 chromenyl	derivatives	exhibited	
potential attenuating activities against carbohydrate hydrolyzing 
enzymes to ameliorate hyperglycemia and associated ailments. 
Additionally,	the	efficacy	of	compound	1 to attenuate insulin se-
cretion	 regulator	 DPP-IV	 appropriately	 attributed	 its	 efficiency	
as an important natural lead against postprandial hyperglycemia 
and incretin hormone regulation in addition with the inhibition of 
active carbohydrate hydrolyzing enzymes α-amylase	and	α-gluco-
sidase to maintain glucose homeostasis in the biological system.
The physicochemical parameters of the chromenyl chemotypes, 
1 and 2 were used to corroborate their free radical scavenging and 
antihyperglycemic	potentials	(Table	2).	The	lipophilic	descriptor	(log	
Pow)	appeared	to	guide	the	inter-membrane	permeability	of	the	me-
tabolites,	and	the	optimum	value	of	1.5–5	was	considered	to	be	effec-
tive	in	maintaining	a	stable	hydrophobic-lipophilic	balance	(Lipinski,	
2004).	Notably,	the	hydrophobic	property	of	the	studied	chromenyl	
derivatives possessed the optimum log Pow	(1.5–2.5)	compared	with	
α-tocopherol	 (log	Pow	 9.98),	 acarbose	 (log	Pow	 −6.85),	 and	diprotin	
A	 (log	 Pow	 0.61).	 Polarizability	 or	 electronic	 system	 of	 a	molecule	
TA B L E  2   In	vitro	bioactive	potentials	(antioxidant	and	antidiabetic)	and	molecular	descriptors	(electronic,	steric,	and	hydrophobic)a of 
compounds 1–2 from S. inermis
Bioactivities
Antioxidant activity(IC50; mg/ml) 1 2 α‐tocopherol
a DPPH	scavenging	activity 0.38a±0.02 0.51b±0.01 0.62c±	0.03
a ABTS+ scavenging activity 0.33a±0.03 0.46b±0.04 0.54c±0.01
Antidiabetic activity (IC50; mg/ml) 1 2 Acarbose
a α-amylase	inhibition	activity 0.27a±0.03 0.36b±0.02 0.13c±0.02
a α-glucosidase	inhibition	activity 0.19a±0.04 0.28b±0.01 0.09c±0.01
   Diprotin A
a DPP-IV	inhibition	activity 0.16a±0.02 0.23b±0.03 0.10c±0.03
Molecular descriptors
 1 2 Acarbose α‐tocopherol Diprotin A
Electronic
tPSA 74.22 43.37 311.94 29.46 112.73
Pl (X10−24 cm3) 36.72 30.99 53.45 53.54 35.93
Steric
MR (cm3/mol) 90.4 80.58 134.61 135.06 91.99
MV	(cm3) 312.5 259.6 347.8 462.70 299.4
Pr (cm3) 791.0 648.0 1,149.4 1,123.00 788.1
Hydrophobic
Log	Pow 1.71 2.16 −6.85 9.98 0.61
Note.	tPSA:	Topological	Polar	Surface	Area;	Pl:	polarizability;	MR:	molar	refractivity;	MV:	molar	volume;	Pr:	parachor;	Log	Pow:	logarithm	of	octanol-
water coefficient. The molecular descriptors were calculated using ChemDraw®	Ultra	(CambridgeSoft	Corporation,	Cambridge,	MA,	USA;	version	8.0)	
and	ACD	ChemSketch	(Advanced	Chemistry	Development,	Inc.,	Canada;	version	12.0)	software.
aThe bioactivities were expressed as IC50	values	(mg/ml).	The	samples	were	analyzed	in	triplicate	(n	=	3)	and	expressed	as	mean	±	SD. Means followed 
by	different	superscripts	(a–c)	within	the	same	row	indicated	significant	differences	(p	<	0.05).	
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was found to play prominent role in modeling the biological activi-
ties	(Almi,	Belaidi,	Lanez,	&	Tchoua,	2014).	The	electronic	parameter	
of compound 1,	referred	in	terms	of	polarizabilty	(Pl),	recorded	sig-
nificantly	greater	value	(Pl	36.72	×	10−24 cm3)	compared	with	those	
displayed by compound 2	(Pl	30.99	×	10−24 cm3)	and	DPP-IV	inhibi-
tor	diprotin	A	(Pl	35.93	×	10−24 cm3).	Likewise	the	topological	polar	
surface	area	(tPSA)	of	the	compound	1	was	greater	(tPSA	74.22)	as	
compared to those recorded with 2	(43.37)	and	standard	antioxidant	
α-tocopherol	 (29.46),	which	 implied	 the	greater	electronic	 interac-
tion of the former might result in efficient free radical scavenging ac-
tivities.	The	lesser	bulk	(steric)	parameters	of	the	studied	compounds	
(MR < 91 cm3/mol;	 MV	<	320	cm3; Pr < 800 cm3)	 might	 contribute	
toward their greater radical scavenging abilities compared to α-to-
copherol	(MV	462.70	cm3;	Pr	1,123	cm3;	MR	135.06	cm3)	and	higher	
hyperglycemic potential to commercially available antidiabetic drug 
acarbose	(MV	347.8	cm3; Pr 1,149.4 cm3;	MR	134.61	cm3).
3.4 | In silico molecular docking analysis of the 
chromenyl derivatives
The molecular docking analyses of the isolated chromenyl de-
rivatives (1–2)	were	performed	against	DPP-IV	enzyme,	and	their	
F I G U R E  3   Closer view of molecular binding interactions of compounds, 1 (a)	and	2	(c)	in	the	binding	site	of	DPP-IV	as	assessed	from	the	
molecular	docking	simulations.	The	black	colored	bond	indicated	the	H‐bonding	interactions	and	corresponding	distance	(Å)	with	the	binding	
site	of	molecular	target	(DPP-IV).	Predicted	molecular	interactions	between	the	chromenyl	analogues	1 and 2 with the active site amino acyl 
residues	of	DPP-IV	(b	and	d).	A	representative	interaction	of	the	amino	acyl	residues	of	DPP-IV,	which	might	interact	with	the	chromenyl	
analogues 1 and 2
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RMSD	results	were	studied	(Figure	3).	DPP-IV	is	a	766	amino	acid	
trans-membrane	glycoprotein	comprising	of	cytoplasmic	tail	(resi-
dues	 1–6),	 a	 trans	membrane	 region	 (residues	 7–28),	 and	 an	 ex-
tracellular	 fragment	 (29–766).	 The	 hydrogen-bonded	 amino	 acyl	
residues and free energy between the chromenyl chemotypes 
and	DPP-IV	active	sites	were	recorded	(Table	3).	In	silico	molecu-
lar	 docking	 analyses	 of	 chromenyl	 derivatives	 with	 DPP-IV	 dis-
closed that the docked ligands could conceivably bind with target, 
and	 displayed	 reduced	 binding	 energies	 (−8.84	 and	 −10.01	kcal/
mol).	 Particularly,	 the	 11-(hexahydro-8-methoxy-4-methyl-
1H-isochromen-4-yloxy)-11-hydroxyethyl	 pentanoate	 deriva-
tive (compound 1)	 registered	 least	 binding	 energy	 (−10.01	kcal/
mol),	 preceded	 by	 that	 of	methyl	 9-(tetrahydro-3-oxo-3H-isoch-
romen-5-yl)	hexanoate	isoform	(compound	2,	−8.84	kcal/mol).	The	
binding energy appeared to reflect the ligand interaction with res-
idues as a principal index to measure inhibitory activity of a ligand 
(Niu,	 Gan,	 Chen,	 &	 Feng,	 2017).	 The	 lesser	 binding	 energy	 of	1 
with	the	enzyme	was	deduced	to	be	coherent	with	its	higher	DPP-
IV	inhibitory	activity	 (IC50	0.16	mg/ml).	The	studied	compound	1 
exhibited	two	hydrogen-bonded	interactions	with	one	amino	acyl	
residue	 SER	 239.A,	 and	 five	 hydrogen-bonded	 interactions	with	
ASP	 708.A,	 THR	 706.A,	 TYR	 238.A,	 GLN	 714.A	 (Figure	 3a,b).	
Chromenyl derivative 1	 displayed	 hydrogen-bonded	 interaction	
with	the	catalytic	domain	 (residues	508–766),	which	showed	the	
α/β	hydrolase-fold	containing	the	catalytic	triad	of	SER	630-ASP	
708-HIS	740	(Kuhn,	Hennig,	&	Mattei,	2007).	The	chromenyl	de-
rivative 2	 displayed	 four	 hydrogen	 bonds	 with	 SER	 239.A,	 SER	
239.B,	TYR	241.A,	GLN	714.A	(Table	3)	(Figure	3c,d).	Additionally,	
the distance of hydrogen bonds between the studied compounds 
(1–2)	and	molecular	receptor	of	DPP-IV	were	deduced	to	be	lesser	
than	3.5	Å,	which	appropriately	recognized	their	effective	binding	
properties	 to	 form	 ligand–protein	 complex	 (Girgih,	He,	&	Aluko,	
2014).	In	the	current	study,	the	ligand	(1)	exhibited	a	binding	en-
ergy	of	−10.01	kcal/mol,	which	was	found	to	be	comparable	with	
the	commercially	available	DPP-IV	inhibitors	namely,	vigildagliptin	
(−7.43	kcal/mol),	and	linagliptin	(−7.91	kcal/mol)	with	DPP-IV	pro-
tein	 target	 (Anitha,	 Gopi,	 Girish,	 &	 Kumar,	 2013).	 The	 inhibition	
constants, Ki and intermolecular energy were found to be lesser 
for compound 1	(46.41	nM	and	−11.20	kcal/mol,	respectively)	than	
those exhibited by compound 2	 (329.67	nM	and	−9.95	kcal/mol).	
These results appropriately corroborated the greater enzyme in-
hibition activities of the chromenyl derivative with 1H-isochrome-
nyloxy-11-hydroxyethyl	 pentanoate	 moiety	 (compound	 1)	 than	
that	 bearing	 3H-isochromenyl	 hexanoate	 framework	 (compound	
2)	against	the	key	regulator	of	insulin	secretion	DPP-IV.
4  | CONCLUSIONS
Two chromenyl analogues were isolated from the spine-
less cuttlefish, Sepiella inermis, and their chemistries were de-
duced by extensive spectroscopic experiments. The potential 
antioxidant and inhibitory activities of the chromenyl analogue T
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with 1H-isochromenyloxy-11-hydroxyethyl	 pentanoate	 framework	
against	 serine	protease	dipeptidyl	peptidase-IV,	 a	 key	 regulator	of	
blood	glucose	level	and	endogenous	active	glucagon-like	peptide-1,	
signified its utilities as potential functional food ingredient. The 
greater antihyperglycemic properties of the 1H-isochromenyloxy	
derivative	were	ascribed	by	 its	optimum	hydrophilic-lipophilic	bal-
ance along with lesser steric bulk for favorable interaction with the 
active	site	amino	acyl	residues	of	dipeptidyl	peptidase-IV	leading	to	
least	binding	energy	of	−10.01	kcal/mol.	The	recognition	of	potential	
antihyperglycemic properties of the chromenyl metabolites isolated 
from S. inermis appropriately recognized their potential as naturally 
occurring lead molecules in the functional food formulations.
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